Gofex Side Effects

Undesirable effects are primary linked to the pharmacological effect of ibuprofen on prostaglandin synthesis. The most commonly reported adverse events effect the gastrointestinal tract, ranging from nausea and dyspepsia to serious bleeding or activation of peptic ulcer (see Precautions).
Bullous reaction including Steven-Johnson's syndrome and toxic epidermal necrolysis were observed very seldom.
Oedema, hypertension, and cardiac failure have been reported in association with NSAIDS treatment. Clinical studies suggest that use of ibuprofen, particularly at high dose (2,400 mg/day) may be associated with a small increased risk of arterial thrombotic events (for example myocardial infraction or stroke) (see Precautions).
In the table as follows adverse reactions are listed by system organ class, and frequency very common (more than or equal to 1/10), common (21/100 to less than 1/10), uncommon (21/1,000 to 1/100), rare (21/10,000 to less than 1/1,000), very rare (less than 1/10,000) and not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. (See table.)


Click on icon to see table/diagram/image


Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions to.
Email: pv-center@pom.go.id.
Phone: +62-21- 4244691 Ext. 1079.
Website: http://e-meso.pom.go.id/.